World's Best Scientists 2026 revealed!
Thomas F. Pajak

Thomas F. Pajak

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 81 16370 15396 8236 7619 252 45156

Thomas F. Pajak publications per year

The chart shows the history of publications by Thomas F. Pajak between 1974 and 2020, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Thomas F. Pajak published across 47 years, from 1974 to 2020, averaging 5.4 papers a year. Output peaked at 14 publications in 1991. 1 of the 252 publications appeared in the last two years.

No. of publications
5 10
Bar chart. Horizontal axis: year, 1974 to 2020. Vertical axis: number of publications, 0 to 14. Peak 14 publications in 1991. 1974: 2 publications 1975: 2 publications 1976: 4 publications 1977: 2 publications 1978: 3 publications 1979: 9 publications 1980: 6 publications 1981: 8 publications 1982: 11 publications 1983: 3 publications 1984: 9 publications 1985: 6 publications 1986: 8 publications 1987: 8 publications 1988: 3 publications 1989: 12 publications 1990: 7 publications 1991: 14 publications 1992: 6 publications 1993: 13 publications 1994: 14 publications 1995: 8 publications 1996: 7 publications 1997: 8 publications 1998: 7 publications 1999: 4 publications 2000: 5 publications 2001: 10 publications 2002: 7 publications 2003: 3 publications 2004: 9 publications 2005: 4 publications 2006: 7 publications 2007: 6 publications 2008: 3 publications 2009: 4 publications 2010: 2 publications 2011: 1 publication 2012: 2 publications 2013: 3 publications 2014: 0 publications 2015: 0 publications 2016: 0 publications 2017: 1 publication 2018: 0 publications 2019: 0 publications 2020: 1 publication
1974 2020

252 publications in total across all disciplines

View publications per year as a table
Thomas F. Pajak: publications per year, 1974 to 2020
Year Publications
1974 2
1975 2
1976 4
1977 2
1978 3
1979 9
1980 6
1981 8
1982 11
1983 3
1984 9
1985 6
1986 8
1987 8
1988 3
1989 12
1990 7
1991 14
1992 6
1993 13
1994 14
1995 8
1996 7
1997 8
1998 7
1999 4
2000 5
2001 10
2002 7
2003 3
2004 9
2005 4
2006 7
2007 6
2008 3
2009 4
2010 2
2011 1
2012 2
2013 3
2014 0
2015 0
2016 0
2017 1
2018 0
2019 0
2020 1
Total 252
Download as CSV

Thomas F. Pajak publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Thomas F. Pajak sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 241–260 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 252 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545 252
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Thomas F. Pajak D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas F. Pajak sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 80–81 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972 81
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Thomas F. Pajak is affiliated with the RTOG Foundation in the United States. The foundation is known for its focus on radiation therapy oncology group research, which suggests Pajak's involvement in areas related to oncology and radiation therapy, though specific fields of study are not explicitly detailed in the available data.

No records of recent papers, frequent co-authors, or common publication venues are listed. This absence limits a detailed understanding of Pajak's specific research contributions or collaborations.

There is no information on books published or main research topics, which further constrains insights into their areas of academic focus or thematic expertise.

Despite the lack of specific bibliographic or thematic data, Thomas F. Pajak's continuous professional affiliation indicates ongoing participation in research activities related to the RTOG Foundation, which is predominantly involved in clinical trials and studies in radiation oncology.

No awards or formal recognitions have been recorded, and Pajak is noted to be currently living.

Best Publications

  • Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)

    James D. Cox;Jo Ann Stetz;Thomas F. Pajak

  • Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

    Arlene A. Forastiere;Helmuth Goepfert;Moshe Maor;Thomas F. Pajak

  • Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

    Jay S. Cooper;Thomas F. Pajak;Arlene A. Forastiere;John Jacobs

  • Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

    Jacques Bernier;Jay S. Cooper;T. F. Pajak;M. Van Glabbeke

  • A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003

    Karen K. Fu;Thomas F. Pajak;Andy Trotti;Christopher U. Jones

  • INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.

    Bruce D. Minsky;Thomas F. Pajak;Robert J. Ginsberg;Thomas M. Pisansky

  • Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

    David P. Kelsen;Robert Ginsberg;Thomas F. Pajak;Daniel G. Sheahan

  • Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

    M Flam;M John;T F Pajak;N Petrelli

  • Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

    Arlene A. Forastiere;Qiang Zhang;Randal S Weber;Moshe H. Maor

  • Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

    Jean Bourhis;Jens Overgaard;Helene Audry;Kian K. Ang

  • Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

    Gerald E. Hanks;Thomas F. Pajak;Arthur Porter;David Grignon

  • Long‐term observations of the patterns of failure in patients with unresectable non‐oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group

    Carlos A. Perez;Thomas F. Pajak;Philip Rubin;Joseph R. Simpson

  • A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.

    J D Cox;N Azarnia;R W Byhardt;K H Shin

  • Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

    Jay S. Cooper;Qiang Zhang;Thomas F. Pajak;Arlene A. Forastiere

  • Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.

    Jay S. Cooper;Thomas F. Pajak;Philip Rubin;Leslie Tupchong

  • Diffuse Malignant Mesothelioma: Prospective Evaluation of 69 Patients

    A P Chahinian;T F Pajak;J F Holland;L Norton

  • Prophylactic Extended-Field Irradiation of Para-aortic Lymph Nodes in Stages IIB and Bulky IB and IIA Cervical Carcinomas: Ten-Year Treatment Results of RTOG 79-20

    Marvin Rotman;Thomas F. Pajak;Kwang Choi;Michelle Clery

  • Prognostic Factors in Prostate Cancer

    David G. Bostwick;David J. Grignon;M. Elizabeth H. Hammond;Mahul B. Amin

  • The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study

    Rachelle M. Lanciano;Thomas F. Pajak;Karen Martz;Gerald E. Hanks

  • A Radiation Therapy Oncology Group (RTOG) phase III randomised study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas; first report of RTOG 9003

    K.K Fu;T.F Pajak;A Trotti;C.U Jones

Frequent Co-Authors

K. Kian Ang
K. Kian Ang The University of Texas MD Anderson Cancer Center
James F. Holland
James F. Holland Icahn School of Medicine at Mount Sinai
James D. Cox
James D. Cox The University of Texas MD Anderson Cancer Center
Arlene A. Forastiere
Arlene A. Forastiere Johns Hopkins University
Carlos A. Perez
Carlos A. Perez The University of Texas Health Science Center at Houston
Adam S. Garden
Adam S. Garden The University of Texas MD Anderson Cancer Center
David J. Grignon
David J. Grignon Indiana University
Morton Coleman
Morton Coleman Cornell University
Jean Bourhis
Jean Bourhis University of Lausanne
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring alternatives to the traditional path of studying Medicine in the USA, online healthcare degrees offer flexible and accessible options. Students eager to fast-track their nursing education can consider 6 month lpn program online opportunities, which provide an accelerated route into practical nursing roles.

Specializations are also possible through online study. If you are interested in mental health, psych np online programs allow registered nurses to earn a graduate degree and qualify as advanced Psychiatric Mental Health Nurse Practitioners.

Beyond direct patient care, healthcare administration is another growing field. For aspiring healthcare leaders, the best online mha programs provide a convenient way to earn a master's in healthcare administration at reputable institutions. Those seeking to minimize tuition costs can explore options listed among the cheapest mha online programs.

Each of these academic paths can open doors to rewarding healthcare careers, whether you aim for clinical practice or leadership roles.

Best Scientists Citing Thomas F. Pajak

Trending Scientists

Recently Published Articles